Tactile Systems Technology, Inc. (TCMD) - Market Cap to Earnings

Corporate emblem and logo of Tactile Medical (TCMD)

Tactile Systems Technology (TCMD) generates revenue through the sale of pneumatic compression systems and ancillary materials for the home treatment of edema and lymphedema. Financial stability relies on insurance company reimbursements, while management mitigates risks associated with Medicare rate changes. The current metric stands at 24.80. The price visualization available on the GURU.Markets page complements data regarding the company's transparent management and strict compliance.

Tactile Systems Technology, Inc. (TCMD): Price to Earnings Ratio from 07/04/2022 to 11/10/2026

Comprehensive metric breakdowns and analytics for Tactile Systems Technology, Inc. (TCMD)

General company analysis:tactilemedical.com - TCMD
Manufactured product of Tactile Systems Technology

Investors must eliminate speculative assets to minimize the risk of capital losses. The P/E ratio determines the market value of a business by calculating the ratio of the current share price to the net profit per share. Analyzing P/E fluctuations allows for the identification of asset overvaluation relative to its actual yield. For Tactile Systems Technology (TCMD), this indicator confirms the fairness of the premium attributed to its monopoly status and stable revenue from the sale of consumables.

Analysis of competing companies

dexcom.com - Market Cap to Net Income|P/E Multiple PEN|NOVT - Market Cap to Earnings|Haemonetics Corp. - Price to Earnings Ratio|P/E Multiple Inspire Medical Systems Inc INSP|PRCT: Price to Earnings Ratio|conmed.com - Market Price to Net Income Ratio|PLSE: P/E Multiple|INMD - Business Payback Period|PMI (Picard Medical Inc.) - P/E Multiple|Price to Earnings Ratio Surmodics Inc. (SRDX)|Price to Earnings Ratio SENS (Senseonics)|NPCE (neuropace.com) - Company Value to Net Income|Price to Earnings Ratio SANUWAVE SNWV|OM - Price to Earnings Ratio|Electromed Inc - P/E Multiple|Market Cap to Earnings LENSAR Inc|RCEL: P/E Multiple|Price to Earnings Multiple PROF|BDMD (Baird Medical Investment Holdings) - P/E Multiple|EDAP Medical (EDAP) - Business Payback Period|P/E Multiple APYX|Price to Earnings Ratio icecure-medical.com ICCM|P/E Multiple LUNG (Pulmonx)|P/E Multiple TELA Bio Inc. TELA|CTSO - Price to Earnings Ratio|SRTS: Price to Earnings Ratio|ZYXI (Zynex Inc) - Price to Earnings Ratio|electroCore - Company Value to Net Income|RBOT (Vicarious Surgical Inc) - P/E Multiple|Market Cap to Earnings Inspira Technologies Oxy B.H.N. Ltd IINN|Price to Earnings Ratio SeaStar Medical (ICU)|iridex.com (IRIX) - Market Cap to Net Income Ratio|Intelligent Bio Solutions Inc. - Price to Earnings Ratio|P/E Multiple Beyond Air Inc XAIR|Profusa Inc - P/E Multiple|Business Payback Period STRATA Skin Sciences SSKN|GlucoTrack, Inc. (GCTK) - Price to Earnings Ratio|Market Cap to Net Income NAOV (nanovibronix.com)|Price to Earnings Ratio Venus Concept Corp|Price to Earnings Ratio Nuwellis Corp (NUWE)|P/E Multiple AEMD|ASXC - Market Cap to Earnings|Price to Earnings Ratio Avinger AVGR|BSGM: Price to Earnings Multiple|CUTR: Price to Earnings Ratio|Know Labs Corporation - Market Price to Net Income Ratio|NARI (Inari Medical, Inc.) - Price to Earnings Ratio|NVRO: Market Price to Net Income Ratio|RSLS (ReShape Lifesciences, Inc.) - P/E Multiple|P/E Multiple Silk Road Medical, Inc.